Ophthalmology Clinical Trials: Strategic Growth, Scientific Innovation, and Execution Risk for Sponsors Key Takeaways Aging populations and chronic disease growth are expanding the patient pool for...
Read More
Patient Centric Clinical Trials: Reducing Transportation Risk to Protect Timelines and Data Integrity Key Takeaways Transportation barriers are not just patient experience issues, they are protocol...
Read More
How to Reduce Patient Dropout Rates in Clinical Trials: Sponsor-Driven Retention Strategies That Protect Timelines Key Takeaways Dropout is a sponsor risk that impacts timelines, data continuity,...
Read More
How Small Operational Gaps Create Big Endpoint Risk in BCVA, OCT, and IOP Testing Key Takeaways BCVA, OCT, and IOP endpoints drift when setup, technique, timing, and documentation are not controlled...
Read More
At-home clinical trials have the potential to improve how research studies are conducted and the level of participation they receive. Learn more about this option and whether it’s appropriate for...
Read More
Hybrid clinical trials combine traditional site-based research with decentralized trial (DCT) elements. These can include remote monitoring via apps and wearable technology, as well as virtual...
Read More